The clinical significance of vascular calcification in young patients with end-stage renal disease
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (5) , 478-484
- https://doi.org/10.1007/s00467-004-1450-z
Abstract
Mortality statistics of young adults with childhood-onset end-stage renal disease (ESRD) show that cardiovascular disease (CVD) is responsible for most deaths on dialysis and after transplantation. This is most likely explained by the presence of a multitude of traditional and non-traditional risk factors in uremia, promoting the combination of classical atherosclerosis, uremic vasculopathy, and uremic cardiomyopathy. Vascular (arterial) calcifications occur with a high prevalence in young adults and their presence correlates with non-traditional risk factors, markers of inflammation, intake of calcium-containing phosphate binders, and the calcium-phosphorus product in serum. This might be explained by a high positive calcium and phosphorus balance in ESRD patients, which may be comparatively higher in the young. In addition, treatment with active vitamin D preparations may enhance the positive calcium and phosphorus balance and have a direct calcifying effect on the arterial wall. The biological process of vascular calcification resembles osteogenesis. These data indicate that vascular calcifications are related to non-traditional risk factors, inflammatory mechanisms, and disturbances in calcium and phosphorus metabolism in uremia. They provide strong evidence for a change in the current management of renal osteodystrophy in children and adolescents with ESRD.Keywords
This publication has 49 references indexed in Scilit:
- Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional studyPublished by Elsevier ,2003
- Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vesselsKidney International, 2003
- 1,25-(OH)2-Vitamin D3 Suppresses the Bone-Related Runx2/Cbfa1 Gene PromoterExperimental Cell Research, 2002
- Improved Cardiovascular Risk Factors and Cardiac Performance after 12 Months of Growth Hormone (GH) Replacement in Young Adult Patients with GH Deficiency1Journal of Clinical Endocrinology & Metabolism, 2001
- Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and managementNephrology Dialysis Transplantation, 2000
- Phosphate Regulation of Vascular Smooth Muscle Cell CalcificationCirculation Research, 2000
- Kidney transplanted children come of ageKidney International, 1999
- Sex differences in symptom presentation associated with acute myocardial infarction: A population-based perspectiveAmerican Heart Journal, 1998
- Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patientsAmerican Journal of Kidney Diseases, 1996
- The prognostic importance of left ventricular geometry in uremic cardiomyopathy.Journal of the American Society of Nephrology, 1995